Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Article
|
Generating comparative evidence on new drugs and devices after approvalThe Lancet (British edition), 2020-03, Vol.395 (10228), p.998-1010 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)33177-0 ;PMID: 32199487Full text available |
|
22 |
Material Type: Article
|
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trialThe Lancet (British edition), 2023-03, Vol.401 (10378), p.733-746 [Peer Reviewed Journal]2023 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)00221-0Full text available |
|
23 |
Material Type: Article
|
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020-03, Vol.395 (10229), p.1054-1062 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30566-3 ;PMID: 32171076Digital Resources/Online E-Resources |
|
24 |
Material Type: Article
|
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UKThe Lancet (British edition), 2020-01, Vol.395 (10219), p.226-239 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32908-3 ;PMID: 31791690Full text available |
|
25 |
Material Type: Article
|
Rebuilding an agenda for Brazilian science and technologyThe Lancet (British edition), 2023-02, Vol.401 (10377), p.642-643 [Peer Reviewed Journal]2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)00098-3 ;PMID: 36841611Full text available |
|
26 |
Material Type: Article
|
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trialThe Lancet (British edition), 2018-06, Vol.391 (10137), p.2335-2345 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 9, 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31082-1 ;PMID: 29803590Full text available |
|
27 |
Material Type: Article
|
From primary health care to universal health coverage—one step forward and two steps backThe Lancet (British edition), 2019-08, Vol.394 (10199), p.619-621 [Peer Reviewed Journal]2019 Elsevier Ltd ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31831-8 ;PMID: 31448726Full text available |
|
28 |
Material Type: Article
|
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016The Lancet (British edition), 2017-09 [Peer Reviewed Journal]info:eu-repo/semantics/openAccess ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32336-XFull text available |
|
29 |
Material Type: Article
|
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trialThe Lancet (British edition), 2019-11, Vol.394 (10210), p.1713-1723 [Peer Reviewed Journal]2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2019. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32233-0 ;PMID: 31623894Full text available |
|
30 |
Material Type: Article
|
Advances in technology for management of type 1 diabetesThe Lancet (British edition), 2019-10, Vol.394 (10205), p.1265-1273 [Peer Reviewed Journal]2019 Elsevier Ltd ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31142-0Full text available |
|
31 |
Material Type: Article
|
Hip arthroscopy versus best conservative care for the treatment of femoroacetabular impingement syndrome (UK FASHIoN): a multicentre randomised controlled trialThe Lancet (British edition), 2018-06, Vol.391 (10136), p.2225-2235 [Peer Reviewed Journal]2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2018. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31202-9 ;PMID: 29893223Full text available |
|
32 |
Material Type: Article
|
Holmes verdicts prompt questions over justice for patientsThe Lancet (British edition), 2022-01, Vol.399 (10321), p.224-225 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00050-2 ;PMID: 35033214Full text available |
|
33 |
Material Type: Article
|
Challenges and opportunities for educating health professionals after the COVID-19 pandemicThe Lancet (British edition), 2022-10, Vol.400 (10362), p.1539-1556 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02092-X ;PMID: 36522209Full text available |
|
34 |
Material Type: Article
|
Circadian rhythms and disorders of the timing of sleepThe Lancet (British edition), 2022-09, Vol.400 (10357), p.1061-1078 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00877-7 ;PMID: 36115370Full text available |
|
35 |
Material Type: Article
|
Levers for addressing medical underuse and overuse: achieving high-value health careThe Lancet (British edition), 2017-07, Vol.390 (10090), p.191-202 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 8, 2017 ;2017. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)32586-7 ;PMID: 28077228Full text available |
|
36 |
Material Type: Article
|
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trialThe Lancet (British edition), 2018-05, Vol.391 (10135), p.2107-2115 [Peer Reviewed Journal]2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited May 26, 2018 ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2018 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31033-X ;PMID: 29778325Full text available |
|
37 |
Material Type: Article
|
Digital health care for older adultsThe Lancet (British edition), 2019-04, Vol.393 (10180), p.1493-1493 [Peer Reviewed Journal]2019 Elsevier Ltd ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)30800-1 ;PMID: 30983579Full text available |
|
38 |
Material Type: Article
|
Gene-edited babies: Chinese Academy of Medical Sciences’ response and actionThe Lancet (British edition), 2019-01, Vol.393 (10166), p.25-26 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright Elsevier Limited Jan 5, 2019 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)33080-0 ;PMID: 30522918Full text available |
|
39 |
Material Type: Article
|
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomyThe Lancet (British edition), 2021-09, Vol.398 (10305), p.1065-1073 [Peer Reviewed Journal]2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01910-3 ;PMID: 34469763Full text available |
|
40 |
Material Type: Article
|
Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trialThe Lancet (British edition), 2020-03, Vol.395 (10228), p.962-972 [Peer Reviewed Journal]2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32984-8 ;PMID: 32087126Full text available |